Get the Stockscreener App
16.00
5.88%
-1.00
After Hours:
16.97
0.97
+6.06%
Seaport Therapeutics Inc stock is traded at $16.00, with a volume of 892.13K.
It is down -5.88% in the last 24 hours and up +0.00% over the past month.
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
See More
Previous Close:
$17.00
Open:
$17.35
24h Volume:
892.13K
Relative Volume:
32.71
Market Cap:
$848.45M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$15.21
$17.86
1-Week Range:
$15.21
$19.17
52-Week Range:
$15.21
$19.17
Seaport Therapeutics Inc Stock (SPTX) Company Profile
Name
Seaport Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare SPTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPTX
Seaport Therapeutics Inc
|
16.00 | 901.47M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seaport Therapeutics Inc Stock (SPTX) Latest News
SPTX News Today | Why did Seaport Therapeutics stock go up today? - MarketBeat
Hemab, Seaport surge as clinical-stage biotechs make trading debuts - MSN
symbol__ Stock Quote Price and Forecast - CNN
SPTX | Seaport Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
SPTX | Seaport Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Diluted earnings per share (diluted EPS) of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Seaport Therapeutics (SPTX) Stock Price, News & Analysis - MarketBeat
SPTX | Seaport Therapeutics, Inc. Common Stock Data, Price & News - Quiver Quantitative
Seaport Therapeutics Inc. (SPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Seaport Therapeutics, Inc (SPTX) Stock Price Today & Analysis - Gotrade
SPTX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Number of employees of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
SPTX Technical Analysis & Stock Price Forecast - Intellectia AI
Seaport Therapeutics (SPTX) Stock Chart and Price History 2026 - MarketBeat
Seaport Therapeutics (SPTX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Diluted earnings per share (diluted EPS) of Seaport Therapeutics, Inc. – BOATS:SPTX - TradingView
Seaport, Hemab price upsized IPOs, eyeing $550M in proceeds - MSN
Assessing Seaport Therapeutics (SPTX) Valuation After Its Recent 10.2% One Day Share Price Move - Yahoo Finance
Seaport and Hemab Therapeutics Launch IPOs, Raising $556 Million - geneonline.com
Seaport Therapeutics, Inc.(NasdaqGS: SPTX) added to NASDAQ Composite Index - marketscreener.com
Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years - MedCity News
Seaport Therapeutics Set For Nasdaq Debut After Raising $255 Million In IPO - Yahoo Finance UK
SPTX Price Today: Seaport Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Psychiatry drugmaker Seaport seeks $212.4 million in US IPO - MSN
SEAPORT THERAPEUTICS INC Revenue Breakdown – NASDAQ:SPTX - TradingView
Latham & Watkins Advises on Seaport Therapeutics’ Upsized US$254.9 Million Initial Public Offering - Legal Desire
Enterprise value of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Diluted net income available to common stockholders of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Net debt of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Non-operating income (total) of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
EBITDA margin % of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
EBITDA per share of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Free cash flow of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Long term debt to total assets ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Total liabilities of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Total debt of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Debt to assets ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Quick ratio of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Total liabilities & shareholders' equities of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Tangible book value per share of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Debt to equity ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Free cash flow per share of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Enterprise value to EBITDA ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
CapEx per share of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Price to cash flow ratio of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
EBIT per share of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Cash per share of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Seaport Therapeutics, Inc. Dividends – NASDAQ:SPTX - TradingView
Net margin % of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Net income of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Cash from operating activities of SEAPORT THERAPEUTICS INC – NASDAQ:SPTX - TradingView
Seaport Therapeutics Inc Stock (SPTX) Financials Data
There is no financial data for Seaport Therapeutics Inc (SPTX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):